Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.6 million shares were traded. DCGO stock price reached its highest trading level at $1.4373 during the session, while it also had its lowest trading level at $1.36.
Ratios:
For a better understanding of DCGO, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.78 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 1.63. For the most recent quarter (mrq), Quick Ratio is recorded 2.44 and its Current Ratio is at 2.44. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.07.
On February 28, 2025, Deutsche Bank Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $5 to $2.85.
On August 18, 2023, BTIG Research started tracking the stock assigning a Buy rating and target price of $15.BTIG Research initiated its Buy rating on August 18, 2023, with a $15 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 23 ’25 when Burdiek Michael J bought 10,000 shares for $1.33 per share. The transaction valued at 13,300 led to the insider holds 641,560 shares of the business.
Burdiek Michael J bought 15,000 shares of DCGO for $21,450 on May 15 ’25. The Director now owns 631,560 shares after completing the transaction at $1.43 per share. On May 14 ’25, another insider, Klasko Stephen K. M.D., who serves as the Director of the company, bought 15,000 shares for $1.49 each. As a result, the insider paid 22,350 and bolstered with 15,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DCGO now has a Market Capitalization of 140728112 and an Enterprise Value of 115164984. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.27 while its Price-to-Book (P/B) ratio in mrq is 0.46. Its current Enterprise Value per Revenue stands at 0.221 whereas that against EBITDA is 8.065.
Stock Price History:
The Beta on a monthly basis for DCGO is 0.96, which has changed by -0.591954 over the last 52 weeks, in comparison to a change of 0.16821623 over the same period for the S&P500. Over the past 52 weeks, DCGO has reached a high of $5.68, while it has fallen to a 52-week low of $1.23. The 50-Day Moving Average of the stock is -4.94%, while the 200-Day Moving Average is calculated to be -53.56%.
Shares Statistics:
Over the past 3-months, DCGO traded about 993.96K shares per day on average, while over the past 10 days, DCGO traded about 445530 shares per day. A total of 100.18M shares are outstanding, with a floating share count of 85.93M. Insiders hold about 13.29% of the company’s shares, while institutions hold 49.64% stake in the company. Shares short for DCGO as of 1752537600 were 5250063 with a Short Ratio of 5.28, compared to 1749772800 on 6022672. Therefore, it implies a Short% of Shares Outstanding of 5250063 and a Short% of Float of 5.4.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The stock of DocGo Inc (DCGO) is currently drawing attention from 2.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.25, with high estimates of -$0.25 and low estimates of -$0.26.
Analysts are recommending an EPS of between -$0.81 and -$0.92 for the fiscal current year, implying an average EPS of -$0.86. EPS for the following year is -$0.02, with 2.0 analysts recommending between $0.25 and -$0.29.
Revenue Estimates
6 analysts predict $77.36M in revenue for the current quarter. It ranges from a high estimate of $81.4M to a low estimate of $74.38M. As of the current estimate, DocGo Inc’s year-ago sales were $164.95MFor the next quarter, 6 analysts are estimating revenue of $68.93M. There is a high estimate of $72.13M for the next quarter, whereas the lowest estimate is $66.51M.
A total of 7 analysts have provided revenue estimates for DCGO’s current fiscal year. The highest revenue estimate was $321.56M, while the lowest revenue estimate was $309M, resulting in an average revenue estimate of $314.67M. In the same quarter a year ago, actual revenue was $616.56MBased on 6 analysts’ estimates, the company’s revenue will be $327.57M in the next fiscal year. The high estimate is $345.5M and the low estimate is $304.45M.
